REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/04/2026
Back to search
Official data from USPTO
ORBLU BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
05/05/2026
Trademark type
Combined
Nice classes
42
Filing date
03/13/2019
Registration date
05/04/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2021
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/04/2019
First use in commerce
01/20/2019
Drawing code
3
Owner type
01
Owner location
Carlsbad, CA, US
Examiner
FLOWERS, JAY K
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "ORBLU" in large blue stylized letters on a white background in the center of the mark. Underneath is the word "biopharma" in a dark blue and smaller stylized lettering. To the left of the words is a design featuring a dark blue solid circle shape surrounded by an arrangement of three sets of various sized dots in three colors, dark, medium and light blue circling around the large central shape.
Holders and representatives
Holders
D. S. (pessoa física)
Representatives
Mariana Paula Noli NOLI IP SOLUTIONS PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research and development
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/01/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/31/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/29/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/29/2020
GNFR
FINAL REFUSAL E-MAILED
09/29/2020
CNFR
SU - FINAL REFUSAL - WRITTEN
09/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/17/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/18/2020
GNRT
NON-FINAL ACTION E-MAILED
03/18/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/18/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/17/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/17/2020
IUAF
USE AMENDMENT FILED
02/26/2020
EISU
TEAS STATEMENT OF USE RECEIVED
02/26/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/16/2019
PUBO
PUBLISHED FOR OPPOSITION
07/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/26/2019
ALIE
ASSIGNED TO LIE
06/10/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
05/28/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/28/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
05/28/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/28/2019
DOCK
ASSIGNED TO EXAMINER
05/22/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2019
NWAP
NEW APPLICATION ENTERED
03/16/2019
Continuous trademark protection
Get notified about every new filing that threatens ORBLU BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.